Creso Pharma Limited

Creso Pharma Limited

Creso was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere.
Biotechnology
1d 5d 1m 6m 1y Max

Creso Pharma Limited News

04 Dec

OpenGate Capital Completes Acquisition of Fichet Security Solutions

Integrated Security Solutions Provider with Operations in France, Belgium and Luxembourg

17 Jul

OpenGate Capital Signs Agreement to Acquire French, Belgium and Luxembourg Businesses from Gunnebo Group of

OpenGate Capital, a global private equity firm, announced today that it has signed a binding offer to acquire the French, Belgium and Luxembourg divisions of Gunnebo Group (GUNN: CPH), a leading provider...

Load more

About Creso Pharma Limited

Creso was founded on the belief that the cannabis space required pharmaceutical expertise and methodological rigour to deliver better health outcomes in people and animals. By developing, registering and commercialising a range of well-tolerated, standardised products produced to the highest quality that are rich in cannabinoids and administered through the latest delivery techniques, Creso seeks to become the world’s most trusted supplier of cannabis and hemp derived products.

Creso Pharma’s Intellectual Property and marketing strategy will help identify global opportunities related to the company’s line of activity: its formulations, delivery platforms, and the therapeutic uses of its cannabinoid-rich products.

Features Creso Pharma Limited

The Creso System is a business strategy designed to develop innovative products by combining:

 

- Cannabis and hemp ingredients

- Pharmaceutical and cannabis expertise

- Novel proprietary technologies for manufacturing and delivery

- Regulatory approvals

- Key strategic partnerships

Team

Miri Halperin Wernli
Group CEO, Co–Founder and Executive Director
Boaz Wachtel
Non-Executive Chairman and Co-Founder
Adam Blumenthal
Non-Executive Director and Co – Founder
John Griese
Chief Operating Officer
James Ellingford
Post Grad Corp Man, AICD Non-Executive Director
Isaac Kobrin
Scientific Industry Advisor, MD
Stéphane Redey
Scientific Industry Advisor, PhD
DR. RAQUEL PEYRAUBE
Scientific Industry Advisor, MD
Felix Gutzwiller
Scientific Industry Advisor
Gian Trepp
Industry Advisor
Jorge Wernli
Industry Advisor
Walter P. von Wartbu...
Industry Advisor

Participation in events

$ 0.00
Symbol:
CPH